Physician profile
Ryan Perry Steck
NPI 1053811620
$1,399.35
in general payments reported to CMS, 2019-2025
10 companies · $460 in 2025
The $460 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $99.99 · 2021: $20.61 · 2022: $37.68 · 2023: $344 · 2024: $437 · 2025: $460.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,241.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,241.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $545.26 | 2021-2025 | Wavelight Ex500 Excimer Laser, Unity, Acrysof, Iq Restor |
| Sight Sciences, INC. | $213.22 | 2022-2025 | Omni Surgical System, Sion Surgical Instrument |
| Carl Zeiss Meditec USA, INC. | $187.15 | 2023 | Visumax |
| Amgen INC. | $174.69 | 2024-2025 | Tepezza |
| Allergan, INC. | $99.99 | 2019 | |
| Dompe US, INC. | $58.39 | 2025 | Oxervate |
| Johnson & Johnson Surgical Vision, INC. | $39.03 | 2025 | Tecnis Iol |
| Sun Pharmaceutical Industries INC. | $34.62 | 2025 | |
| Harrow Eye, LLC | $29.09 | 2024 | Vevye |
| Carl Zeiss Meditec Cataract Technology INC. | $17.91 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Steck listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.